Canine sarcoma case points to pediatric immunotherapy research

A Washington State University veterinary team says a 6-year-old silver Labrador retriever named Clarice is cancer-free after receiving a multimodal treatment plan for a malignant soft tissue sarcoma near her left wrist, a location where amputation is often recommended. The care plan combined an intratumoral immune-stimulating injection delivered through a clinical trial run in partnership with Seattle Children’s Hospital, followed one week later by surgery and then a three-round course of radiation completed in early January 2026. WSU said the case is part of a comparative oncology effort aimed at informing immunotherapy strategies for difficult-to-treat sarcomas in both dogs and children. (news.wsu.edu)

Why it matters: For veterinary professionals, the case highlights how referral centers are testing whether local immunotherapy can improve limb-sparing options for canine soft tissue sarcoma when wide margins are hard to achieve. WSU notes soft tissue sarcomas account for about 15% of malignant tumors in dogs, and the hospital has an active clinical study on local immunotherapy for these cases. The report also underscores how newer radiation capacity, including WSU’s LINAC installed in 2023, can support multimodal oncology care after incomplete or anatomically constrained resections. (news.wsu.edu)

What to watch: Watch for follow-up data from WSU’s canine soft tissue sarcoma immunotherapy study, including recurrence outcomes, tolerability, and whether the canine findings translate into pediatric sarcoma research collaborations. (vetmed.wsu.edu)